You don't need to be signed in to read BMJ Blogs, but you can register here to receive updates about other BMJ products and services via our site.

Statin treatment and risk of developing diabetes

27 Jun, 13 | by kuppell

A study looking into whether there is an association between statin use and new onset diabetes found that patients treated with atorvastatin, rosuvastatin, or simvastatin were at an increased risk of new onset diabetes compared with those treated with pravastatin.

Researchers conducted a population-based retrospective cohort study in patients aged 66 years and older in Ontario, Canada who started treatment with a statin from 1 August 1997 to 31 March 2010. They examined the healthcare records of more than 1.5 million older people. The analysis was restricted to new users who had not been prescribed a statin in at least the preceding year and patients with established diabetes before the start of treatment were excluded. The primary outcome was incident diabetes. Over the 14 year study period, the researchers identified 471,250 patients with no history of diabetes who were newly treated with a statin. Of these patients, 227,994 (48.3%) received a statin for primary prevention, while 243,256 (51.7%) received a statin for secondary prevention.

Reporting their findings in the British Medical Journal the researchers say that, compared with pravastatin, there was an increased risk of incident diabetes with atorvastatin (adjusted HR 1.22, 95% CI 1.15 to 1.29), rosuvastatin (1.18, 1.10 to 1.26) and simvastatin (1.10, 1.04 to 1.17). There was no significantly increased risk among patients who received fluvastatin or lovastatin and the risk of incident diabetes was similar whether statins were used for primary or secondary prevention. BMJ 2013;346:f2610.

(Visited 6 times, 1 visits today)
By submitting your comment you agree to adhere to these terms and conditions
You can follow any responses to this entry through the RSS 2.0 feed.

Latest from European Journal of Hospital Pharmacy

Latest from European Journal of Hospital Pharmacy